Leaflet REVIA 50mg film-coated tablets
- Product code:
- W43351003
- Quantity:
- 28
- Indicated for:
- opioid dependence; alcohol dependence
- Route of administration:
- oral
- Substance:
- naltrexone (opioid antagonist)
- ATC
- N07BB04 — Nervous system | Drugs used in addictive disorders | Drugs used in alcohol dependence
Naltrexone is an opioid receptor antagonist used for the treatment of opioid and alcohol dependence. It works by blocking the effects of opioids and reducing cravings, helping patients maintain abstinence.
The medication is taken orally, usually once daily, with the dose adjusted based on the patient's needs. Common side effects include nausea, headaches, insomnia, and irritability.
Naltrexone is contraindicated in patients actively using opioids or with severe hepatic impairment. Its use also requires careful monitoring to prevent severe adverse reactions.
This medication is an important option for patients seeking to quit opioids or alcohol, helping to reduce relapses and improve quality of life.
The medication is taken orally, usually once daily, with the dose adjusted based on the patient's needs. Common side effects include nausea, headaches, insomnia, and irritability.
Naltrexone is contraindicated in patients actively using opioids or with severe hepatic impairment. Its use also requires careful monitoring to prevent severe adverse reactions.
This medication is an important option for patients seeking to quit opioids or alcohol, helping to reduce relapses and improve quality of life.
General data about REVIA 50mg
- Substance:
- naltrexone
- Date of latest medicines list:
- 01-07-2014
- Product code:
- W43351003
- Concentration:
- 50mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 28
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.